StockTipsArenaBeta

BUY Eris Lifesciences Limited — BOB Capital Markets

BUYEris Lifesciences Limited

byBOB Capital MarketsHorizon: NA (inferred 1 year)15 Feb 2026via Institutional / Brokerage Research

Entry₹1,414.4Inferred
Target₹1,756
Total upside +24.15%
Stop lossNot given
CMP₹1,324.33h ago
Active-6.37%+32.60%upside left 5 mo left
Follow BOB Capital Markets for new calls(63% target hit, 356 closed calls)Get alertsWatch ERIS for new buy/sell callsGet alertsSee 4 other Long-term calls on ERISSee 39 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 7:41 pm IST
6 supporting7 neutral1 opposing
Supports the BUY call (6)

Eris Lifesciences: லாபத்தில் **73%** அதிரடி வளர்ச்சி - பங்கு முதலீட்டாளர்கள் கவனத்திற்கு!

NewsGoogle News·2 Sept · 5d ago

(opens in new tab)

Eris Lifesciences FY26 Revenue ₹3,129 Cr

NewsGoogle News·2 Sept · 5d ago

(opens in new tab)

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 1w ago

(opens in new tab)

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·28 Aug · 1w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·9 Jul · 2mo ago

Neutral / worth noting (7)

Eris Lifesciences schedules analyst meet with HBM Partners on August 27

NewsGoogle News·24 Aug · 2w ago

(opens in new tab)

Eris Lifesciences posts analyst call transcript for Q4FY26

NewsGoogle News·23 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·4 Sept · 3d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.